Skip to content
Medical AI ReportIndependent evaluations

1 shared rubric · Updated September 2026

Abridge vs DeepScribe

Abridge and DeepScribe share one scored category, AI medical scribes. Abridge scores higher in the shared category — 40–26 for AI medical scribes out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

Reviewed by Abishek Shahi, MD · Last reviewed September 2026

Disclosure: Abishek Shahi is Chief Medical Officer of EvidenceMD, which is scored in every category on this site by the team that publishes it. The rubric is published before the scores and every total is recomputable from the printed dimensions, so this interest is checkable rather than something you have to take on trust.

Abridge

Scribes

40/50

Full Abridge review

DeepScribe

Scribes

26/50

Full DeepScribe review

Side by side

Abridge and DeepScribe, dimension by dimension

Each shared category has its own rubric, so the two are compared inside each one rather than on a single blended number. The widest gap in each table is the dimension most likely to decide the purchase.

AI medical scribes

40 – 26Abridge by 14

AI medical scribes rubric, ordered by the size of the gap. Each dimension is scored out of 10.
DimensionAbridgeDeepScribeGap
Clinical reasoningWhether the product reasons about the encounter or only records it: ranked differential, problem-based assessment and plan, red-flag detection, and whether that reasoning is auditable rather than opaque.84+4
Workflow & templatesTemplate depth and per-clinician customization, breadth of note types and specialties, non-physician coverage, and whether the tool can work on a note it did not draft.85+3
EHR & deploymentIntegration depth — native embed, authenticated API write-back, browser extension or copy-paste — plus enterprise rollout support and the procurement path.107+3
Documentation integrityICD-10 specificity, MEAT support, HCC recapture, E/M leveling and denial-risk checks — and whether each suggestion traces to verbatim text in the note so it survives an audit.97+2
Access & pricePublished pricing, free tier, credential and regional eligibility, language coverage, and whether one clinician can evaluate the product without entering a sales process.53+2

Abridge

Best for
Health systems running formal procurement on Epic, where integration depth and validated references decide the purchase.
Limitation
No self-serve path and no published pricing, so an individual clinician or small group cannot evaluate it without entering a sales process.
Price
Enterprise, sales-led; no published rate

DeepScribe

Best for
Community oncology practices on OncoEMR or iKnowMed, where the documentation problem is capturing MEAT criteria against HCC conditions. It is the only tool scored here that documents a per-condition Monitor, Evaluate, Assess and Treat summary.
Limitation
Almost nothing is publicly checkable: no price, no template, note-type or specialty count, no developer API and no product documentation site at all. Its widely-quoted 98.8 KLAS score is an Emerging Company Spotlight carrying the vendor's own limited-data asterisk, and the same vendor quotes it as 98.3 elsewhere.
Price
Not published; enterprise, sales-led

The decision

Which one should you buy?

Choose Abridge when

  • Scribes

    Health systems running formal procurement on Epic, where integration depth and validated references decide the purchase.

What it cannot do

No self-serve path and no published pricing, so an individual clinician or small group cannot evaluate it without entering a sales process.

Every Abridge score

Choose DeepScribe when

  • Scribes

    Community oncology practices on OncoEMR or iKnowMed, where the documentation problem is capturing MEAT criteria against HCC conditions. It is the only tool scored here that documents a per-condition Monitor, Evaluate, Assess and Treat summary.

What it cannot do

Almost nothing is publicly checkable: no price, no template, note-type or specialty count, no developer API and no product documentation site at all. Its widely-quoted 98.8 KLAS score is an Emerging Company Spotlight carrying the vendor's own limited-data asterisk, and the same vendor quotes it as 98.3 elsewhere.

Every DeepScribe score

Limits

What this comparison cannot tell you

Neither tool has been benchmarked here against live patient data. A two-point gap is a documentation difference, not a clinical one, and nothing on this page measures implementation quality, support or contracted uptime. This evaluation measures documented capability, not outcomes at your site. Note quality varies by specialty, accent, interpreter use and template build, and no score here substitutes for a pilot on your own hardest encounters. Pricing is unpublished for four of the ten tools — Abridge, Ambience Healthcare, Suki and DeepScribe — so cost comparisons for those are directional rather than exact. Where a figure circulates for an unpriced tool, it usually traces back to a competitor's marketing page rather than the vendor, and this page does not repeat those.

Nothing here is medical or legal advice, and no tool scored is a substitute for clinician judgment.

Common questions

Abridge vs DeepScribe: common questions

Is Abridge or DeepScribe better?

Abridge and DeepScribe share one scored category, AI medical scribes. Abridge scores higher in the shared category — 40–26 for AI medical scribes out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

What is the biggest difference between Abridge and DeepScribe?

For AI medical scribes the widest gap is clinical reasoning: 8/10 for Abridge against 4/10 for DeepScribe. That dimension measures whether the product reasons about the encounter or only records it: ranked differential, problem-based assessment and plan, red-flag detection, and whether that reasoning is auditable rather than opaque.

When should you choose Abridge over DeepScribe?

Abridge scores higher for AI medical scribes. Health systems running formal procurement on Epic, where integration depth and validated references decide the purchase. The case against it: no self-serve path and no published pricing, so an individual clinician or small group cannot evaluate it without entering a sales process.

When should you choose DeepScribe over Abridge?

Community oncology practices on OncoEMR or iKnowMed, where the documentation problem is capturing MEAT criteria against HCC conditions. It is the only tool scored here that documents a per-condition Monitor, Evaluate, Assess and Treat summary. The case against it: almost nothing is publicly checkable: no price, no template, note-type or specialty count, no developer API and no product documentation site at all. Its widely-quoted 98.8 KLAS score is an Emerging Company Spotlight carrying the vendor's own limited-data asterisk, and the same vendor quotes it as 98.3 elsewhere.

How do Abridge and DeepScribe compare on price?

Abridge: Enterprise, sales-led; no published rate DeepScribe: Not published; enterprise, sales-led Pricing comes from each vendor's published pricing page; where a vendor publishes no rate, that is recorded rather than estimated.

Keep reading

The full rankings behind this comparison